Johnson & Johnson Biom X Inc. Transaction History

Johnson & Johnson

$293 Million
Q4 2024

A detailed history of Johnson & Johnson transactions in Biom X Inc. stock. As of the latest transaction made, Johnson & Johnson holds 96,866 shares of PHGE stock, worth $61,025. This represents 0.02% of its overall portfolio holdings.

Number of Shares

96,866

Previous 192,321 49.63%

Holding current value

$61,025

Previous $196,000 64.8%

% of portfolio

0.02%

Previous 0.06%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$0.51 - $1.02 $48,682 - $97,364	-95,455 Reduced 49.63%	96,866 $69,000
Q3 2024 Nov 13, 2024	SELL	$0.14 - $1.4 $242,323 - $2.42 Million	-1,730,880 Reduced 90.0%	192,321 $196,000
Q1 2024 May 10, 2024	SELL	$0.21 - $0.69 $44,142 - $145,038	-210,201 Reduced 9.85%	1,923,201 $865,000
Q3 2021 Nov 12, 2021	BUY	$30.6 - $58.1 $65.3 Million - $124 Million	2,133,402 New	2,133,402 $6.53 Million

Others Institutions Holding PHGE

# of Institutions

Shares Held

96.9K

Call Options Held

Put Options Held

View Full List

About BiomX Inc.

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $18.9M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

More about PHGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Account